Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers

64Cu/68Ga DOTATATE-PET/CT Imaging Protocol & Workflow for Somatostatin Receptor-Positive Head & Neck Tumors: A Collaborative Approach

Josephine Rini, Graham Keir, Christopher Caravella, Anuj Goenka and Ana Franceschi
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P55;
Josephine Rini
1Northwell Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham Keir
1Northwell Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Caravella
1Northwell Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anuj Goenka
1Northwell Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Franceschi
1Northwell Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 64 no. supplement 1 P55

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 28, 2023.

Copyright & Usage 
© 2023

Author Information

  1. Josephine Rini,
  2. Graham Keir,
  3. Christopher Caravella,
  4. Anuj Goenka and
  5. Ana Franceschi
  1. 1Northwell Health

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2023 to April 2025

AbstractFullPdf
Aug 2023600
Sep 20232800
Oct 2023900
Nov 20232200
Dec 20231800
Jan 20244100
Feb 20241500
Mar 20241000
Apr 20244300
May 20241300
Jun 20244300
Jul 202410400
Aug 20249700
Sep 20243000
Oct 20243000
Nov 20245700
Dec 20245100
Jan 20255000
Feb 20256500
Mar 20256000
Apr 20257900
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
64Cu/68Ga DOTATATE-PET/CT Imaging Protocol & Workflow for Somatostatin Receptor-Positive Head & Neck Tumors: A Collaborative Approach
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
64Cu/68Ga DOTATATE-PET/CT Imaging Protocol & Workflow for Somatostatin Receptor-Positive Head & Neck Tumors: A Collaborative Approach
Josephine Rini, Graham Keir, Christopher Caravella, Anuj Goenka, Ana Franceschi
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P55;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
64Cu/68Ga DOTATATE-PET/CT Imaging Protocol & Workflow for Somatostatin Receptor-Positive Head & Neck Tumors: A Collaborative Approach
Josephine Rini, Graham Keir, Christopher Caravella, Anuj Goenka, Ana Franceschi
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P55;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Diagnostic value of PET/MR in Functional nodules of Primary Aldosteronism
  • The Role of Metabolic Parameters in FDG PET-CT Imaging for Predicting Progression-Free Survival in Radioiodine Refractory Thyroid Cancer: A Single-Center Study
  • The value of PET/MR in evaluating the amplification of MYCN gene in children with neuroblastoma
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - Endocrine/Neuroendocrine Cancers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire